DAP · Class II · 21 CFR 864.7320

FDA Product Code DAP: Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

Under FDA product code DAP, fibrinogen and fibrin split product antigen/antibody detection systems are cleared for the evaluation of coagulation disorders.

These tests measure fibrin degradation products and D-dimer in plasma to detect excessive fibrinolysis, disseminated intravascular coagulation, and venous thromboembolism. Elevated FDP and D-dimer indicate ongoing coagulation and fibrinolysis activity.

DAP devices are Class II medical devices, regulated under 21 CFR 864.7320 and reviewed by the FDA Hematology panel.

Leading manufacturers include Instrumentation Laboratory CO, Dade Behring, Inc. and Organon Teknika Corp..

58
Total
58
Cleared
139d
Avg days
1986
Since
Growing category - 1 submissions in the last 2 years vs 0 in the prior period
Review times increasing: avg 242d recently vs 137d historically

FDA 510(k) Cleared Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control Devices (Product Code DAP)

58 devices
1–24 of 58
Cleared Aug 11, 2026
INNOVANCE® D-Dimer 2.0 (SMN 10873803)
K253985
Siemens Healthcare Diagnostic Products GmbH
Hematology · 242d
Cleared Nov 22, 2017
HemosIL D-Dimer HS 500
K172903
Instrumentation Laboratory CO
Hematology · 61d
Cleared Dec 10, 2016
STA® - Liatest® D-Di
K162227
Diagnostica-Stago
Hematology · 124d
Cleared Oct 27, 2016
HemosIL D-Dimer HS
K160885
Instrumentation Laboratory CO
Hematology · 210d
Cleared Jul 06, 2015
HemosIL D-Dimer HS
K151534
Instrumentation Laboratory CO
Hematology · 28d
Cleared Sep 03, 2014
STA LIATEST D-DI
K141144
Diagnostica-Stago
Hematology · 124d
Cleared Jul 31, 2012
VIDAS D-DIMER EXCLUSION II (DEX2)
K112818
bioMerieux, Inc.
Hematology · 307d
Cleared May 16, 2011
STRATUS CS ACUTE CARE D-DIMER
K110303
Siemens Healthcare Diagnostics
Hematology · 104d
Cleared Nov 29, 2010
INNOVANCE D-DIMER, MODEL OPBP09
K093626
Siemens Healthcare Diagnostics
Hematology · 370d
Cleared Feb 05, 2010
HEMOSIL D-DIMER HS 500, CONTROLS
K090264
Instrumentation Laboratory CO
Hematology · 367d
Cleared Oct 29, 2009
INNOVANCE D-DIMER, MODEL OPBP09
K091916
Siemens Healthcare Diagnostics
Hematology · 121d
Cleared Oct 24, 2008
INNOVANCE D-DIMER AND INNOVANCE D-DIMER CONTROLS
K081732
Siemens Healthcare Diagnostics
Hematology · 127d
Cleared Sep 17, 2007
HEMOSIL D-DIMER HS
K070927
Instrumentation Laboratory CO
Hematology · 167d
Cleared Mar 23, 2007
STRATUS CS ACUTE CARE D-DIMER TESTPAK, DILPAK, CALPAK
K063356
Dade Behring, Inc.
Hematology · 136d
Cleared Aug 17, 2005
STRATUS CS D-DIMER
K051597
Dade Behring, Inc.
Hematology · 62d
Cleared Apr 26, 2005
HEMOSIL D-DIMER HS
K050544
Instrumentation Laboratory CO
Hematology · 55d
Cleared Mar 10, 2005
HEMOSIL D-DIMER
K050278
Instrumentation Laboratory CO
Hematology · 31d
Cleared Dec 07, 2004
TRIGAGE PROFILER S.O.B. PANEL, MODEL 97300
K042723
Biosite Incorporated
Chemistry · 67d
Cleared Sep 01, 2004
ROCHE DIAGNOSTICS CARDIAC D-DIMER RAPID ASSAY
K033491
Roche Diagnostics Corp.
Hematology · 302d
Cleared Aug 11, 2004
ADVANCED D-DIMER ASSAY
K041438
Dade Behring, Inc.
Hematology · 71d
Cleared Jun 25, 2004
TRIAGE PROFILER S.O.B. PANEL
K040437
Biosite Incorporated
Chemistry · 127d
Cleared Jun 10, 2004
VIDAS D-DIMER EXCLUSION ASSAY, MODEL 30 442
K040882
bioMerieux, Inc.
Hematology · 66d
Cleared Oct 24, 2003
QUANTEX D-DIMER
K032419
Instrumentation Laboratory CO
Hematology · 80d
Cleared Sep 02, 2003
VIDAS D-DIMER NEW (DD2) ASSAY, MODEL 30 442
K030328
bioMerieux, Inc.
Hematology · 214d

About Product Code DAP - Regulatory Context

510(k) Submission Activity

58 total 510(k) submissions under product code DAP since 1986, with 58 receiving FDA clearance (average review time: 139 days).

Submission volume has increased in recent years - 1 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

FDA 510(k) Review Time - DAP Product Code

Recent submissions under DAP have taken an average of 242 days to reach a decision - up from 137 days historically. Manufacturers should account for longer review timelines in current project planning.

DAP devices are reviewed by the Hematology panel. Browse all Hematology devices →